 | • レポートコード：GIR201115666 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、不妊治療の世界市場を調査対象にし、不妊治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（女性不妊検査、男性不妊検査）、用途別分析（病院、クリニック、不妊治療センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Merck、BioZhena、Abbott、BioMerieux、Ferring Pharmaceuticals ・企業別売上、市場シェア ・不妊治療の地域別市場分析 ・不妊治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・不妊治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・不妊治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・不妊治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・不妊治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・不妊治療の種類別市場規模2015-2020：女性不妊検査、男性不妊検査 ・不妊治療の用途別市場規模2015-2020：病院、クリニック、不妊治療センター、その他 ・不妊治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Infertility Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Infertility Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Infertility Therapies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Infertility Therapies market has been segmented into:
Female Infertility Testing
Male Infertility Testing
By Application, Infertility Therapies has been segmented into:
Hospitals
Clinics
Fertility Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Infertility Therapies market presented in the report. This section sheds light on the sales growth of different regional and country-level Infertility Therapies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Infertility Therapies market.
The report offers in-depth assessment of the growth and other aspects of the Infertility Therapies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Infertility Therapies Market Share Analysis
Infertility Therapies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Infertility Therapies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Infertility Therapies sales, revenue and market share for each player covered in this report.
The major players covered in Infertility Therapies are:
Merck
BioZhena
Abbott
BioMerieux
Ferring Pharmaceuticals
1 Infertility Therapies Market Overview
1.1 Product Overview and Scope of Infertility Therapies
1.2 Classification of Infertility Therapies by Type
1.2.1 Global Infertility Therapies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Infertility Therapies Revenue Market Share by Type in 2019
1.2.3 Female Infertility Testing
1.2.4 Male Infertility Testing
1.3 Global Infertility Therapies Market by Application
1.3.1 Overview: Global Infertility Therapies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Fertility Centers
1.3.5 Others
1.4 Global Infertility Therapies Market by Regions
1.4.1 Global Infertility Therapies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Infertility Therapies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Infertility Therapies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Infertility Therapies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infertility Therapies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Infertility Therapies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infertility Therapies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Infertility Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioZhena
2.2.1 BioZhena Details
2.2.2 BioZhena Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioZhena SWOT Analysis
2.2.4 BioZhena Product and Services
2.2.5 BioZhena Infertility Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Infertility Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioMerieux
2.4.1 BioMerieux Details
2.4.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioMerieux SWOT Analysis
2.4.4 BioMerieux Product and Services
2.4.5 BioMerieux Infertility Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ferring Pharmaceuticals
2.5.1 Ferring Pharmaceuticals Details
2.5.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ferring Pharmaceuticals SWOT Analysis
2.5.4 Ferring Pharmaceuticals Product and Services
2.5.5 Ferring Pharmaceuticals Infertility Therapies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Infertility Therapies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Infertility Therapies Players Market Share
3.2.2 Top 10 Infertility Therapies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Infertility Therapies Revenue and Market Share by Regions
4.2 North America Infertility Therapies Revenue and Growth Rate (2015-2020)
4.3 Europe Infertility Therapies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Infertility Therapies Revenue and Growth Rate (2015-2020)
4.5 South America Infertility Therapies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Infertility Therapies Revenue and Growth Rate (2015-2020)
5 North America Infertility Therapies Revenue by Countries
5.1 North America Infertility Therapies Revenue by Countries (2015-2020)
5.2 USA Infertility Therapies Revenue and Growth Rate (2015-2020)
5.3 Canada Infertility Therapies Revenue and Growth Rate (2015-2020)
5.4 Mexico Infertility Therapies Revenue and Growth Rate (2015-2020)
6 Europe Infertility Therapies Revenue by Countries
6.1 Europe Infertility Therapies Revenue by Countries (2015-2020)
6.2 Germany Infertility Therapies Revenue and Growth Rate (2015-2020)
6.3 UK Infertility Therapies Revenue and Growth Rate (2015-2020)
6.4 France Infertility Therapies Revenue and Growth Rate (2015-2020)
6.5 Russia Infertility Therapies Revenue and Growth Rate (2015-2020)
6.6 Italy Infertility Therapies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Infertility Therapies Revenue by Countries
7.1 Asia-Pacific Infertility Therapies Revenue by Countries (2015-2020)
7.2 China Infertility Therapies Revenue and Growth Rate (2015-2020)
7.3 Japan Infertility Therapies Revenue and Growth Rate (2015-2020)
7.4 Korea Infertility Therapies Revenue and Growth Rate (2015-2020)
7.5 India Infertility Therapies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Infertility Therapies Revenue and Growth Rate (2015-2020)
8 South America Infertility Therapies Revenue by Countries
8.1 South America Infertility Therapies Revenue by Countries (2015-2020)
8.2 Brazil Infertility Therapies Revenue and Growth Rate (2015-2020)
8.3 Argentina Infertility Therapies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Infertility Therapies by Countries
9.1 Middle East & Africa Infertility Therapies Revenue by Countries (2015-2020)
9.2 Saudi Arabia Infertility Therapies Revenue and Growth Rate (2015-2020)
9.3 UAE Infertility Therapies Revenue and Growth Rate (2015-2020)
9.4 Egypt Infertility Therapies Revenue and Growth Rate (2015-2020)
9.5 South Africa Infertility Therapies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Infertility Therapies Revenue and Market Share by Type (2015-2020)
10.2 Global Infertility Therapies Market Forecast by Type (2019-2024)
10.3 Female Infertility Testing Revenue Growth Rate (2015-2025)
10.4 Male Infertility Testing Revenue Growth Rate (2015-2025)
11 Global Infertility Therapies Market Segment by Application
11.1 Global Infertility Therapies Revenue Market Share by Application (2015-2020)
11.2 Infertility Therapies Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Fertility Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Infertility Therapies Market Size Forecast (2021-2025)
12.1 Global Infertility Therapies Market Size Forecast (2021-2025)
12.2 Global Infertility Therapies Market Forecast by Regions (2021-2025)
12.3 North America Infertility Therapies Revenue Market Forecast (2021-2025)
12.4 Europe Infertility Therapies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Infertility Therapies Revenue Market Forecast (2021-2025)
12.6 South America Infertility Therapies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Infertility Therapies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Infertility Therapies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Infertility Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Infertility Therapies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Infertility Therapies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Infertility Therapies Major Business
Table 7. Merck Infertility Therapies Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Infertility Therapies Product and Solutions
Table 10. Merck Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. BioZhena Corporate Information, Location and Competitors
Table 12. BioZhena Infertility Therapies Major Business
Table 13. BioZhena Infertility Therapies Total Revenue (USD Million) (2018-2019)
Table 14. BioZhena SWOT Analysis
Table 15. BioZhena Infertility Therapies Product and Solutions
Table 16. BioZhena Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbott Corporate Information, Location and Competitors
Table 18. Abbott Infertility Therapies Major Business
Table 19. Abbott Infertility Therapies Total Revenue (USD Million) (2017-2018)
Table 20. Abbott SWOT Analysis
Table 21. Abbott Infertility Therapies Product and Solutions
Table 22. Abbott Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BioMerieux Corporate Information, Location and Competitors
Table 24. BioMerieux Infertility Therapies Major Business
Table 25. BioMerieux Infertility Therapies Total Revenue (USD Million) (2017-2018)
Table 26. BioMerieux SWOT Analysis
Table 27. BioMerieux Infertility Therapies Product and Solutions
Table 28. BioMerieux Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ferring Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Ferring Pharmaceuticals Infertility Therapies Major Business
Table 31. Ferring Pharmaceuticals Infertility Therapies Total Revenue (USD Million) (2017-2018)
Table 32. Ferring Pharmaceuticals SWOT Analysis
Table 33. Ferring Pharmaceuticals Infertility Therapies Product and Solutions
Table 34. Ferring Pharmaceuticals Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Infertility Therapies Revenue (Million USD) by Players (2015-2020)
Table 36. Global Infertility Therapies Revenue Share by Players (2015-2020)
Table 37. Global Infertility Therapies Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Infertility Therapies Revenue Market Share by Regions (2015-2020)
Table 39. North America Infertility Therapies Revenue by Countries (2015-2020)
Table 40. North America Infertility Therapies Revenue Market Share by Countries (2015-2020)
Table 41. Europe Infertility Therapies Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Infertility Therapies Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Infertility Therapies Revenue by Countries (2015-2020)
Table 44. South America Infertility Therapies Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Infertility Therapies Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Infertility Therapies Revenue Market Share by Countries (2015-2020)
Table 47. Global Infertility Therapies Revenue (Million USD) by Type (2015-2020)
Table 48. Global Infertility Therapies Revenue Share by Type (2015-2020)
Table 49. Global Infertility Therapies Revenue Forecast by Type (2021-2025)
Table 50. Global Infertility Therapies Revenue by Application (2015-2020)
Table 51. Global Infertility Therapies Revenue Share by Application (2015-2020)
Table 52. Global Infertility Therapies Revenue Forecast by Application (2021-2025)
Table 53. Global Infertility Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Infertility Therapies Picture
Figure 2. Global Infertility Therapies Revenue Market Share by Type in 2019
Figure 3. Female Infertility Testing Picture
Figure 4. Male Infertility Testing Picture
Figure 5. Infertility Therapies Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Fertility Centers Picture
Figure 9. Others Picture
Figure 10. Global Infertility Therapies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Infertility Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Infertility Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Infertility Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Infertility Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Infertility Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Infertility Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Infertility Therapies Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Infertility Therapies Revenue Market Share in 2019
Figure 19. Global Top 10 Players Infertility Therapies Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Infertility Therapies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Infertility Therapies Revenue Market Share by Regions (2015-2020)
Figure 23. Global Infertility Therapies Revenue Market Share by Regions in 2018
Figure 24. North America Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 25. Europe Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 27. South America Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 29. North America Infertility Therapies Revenue Market Share by Countries (2015-2020)
Figure 30. North America Infertility Therapies Revenue Market Share by Countries in 2019
Figure 31. USA Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 32. Canada Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 34. Europe Infertility Therapies Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Infertility Therapies Revenue Market Share by Countries in 2019
Figure 36. Germany Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 37. UK Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 38. France Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 39. Russia Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 40. Italy Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Infertility Therapies Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Infertility Therapies Revenue Market Share by Countries in 2019
Figure 43. China Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 44. Japan Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 45. Korea Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 46. India Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 48. South America Infertility Therapies Revenue Market Share by Countries (2015-2020)
Figure 49. South America Infertility Therapies Revenue Market Share by Countries in 2019
Figure 50. Brazil Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Infertility Therapies Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Infertility Therapies Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 55. UAE Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Infertility Therapies Revenue and Growth Rate (2015-2020)
Figure 58. Global Infertility Therapies Revenue Share by Type (2015-2020)
Figure 59. Global Infertility Therapies Revenue Share by Type in 2019
Figure 60. Global Infertility Therapies Market Share Forecast by Type (2021-2025)
Figure 61. Global Female Infertility Testing Revenue Growth Rate (2015-2020)
Figure 62. Global Male Infertility Testing Revenue Growth Rate (2015-2020)
Figure 63. Global Infertility Therapies Revenue Share by Application (2015-2020)
Figure 64. Global Infertility Therapies Revenue Share by Application in 2019
Figure 65. Global Infertility Therapies Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Fertility Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Infertility Therapies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Infertility Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Infertility Therapies Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Infertility Therapies Revenue Market Forecast (2021-2025)
Figure 74. Europe Infertility Therapies Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Infertility Therapies Revenue Market Forecast (2021-2025)
Figure 76. South America Infertility Therapies Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Infertility Therapies Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
遺伝子組み換え療法の世界市場 2020年 Market Overview The global Genetic Modification Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genetic Modifi…- 重症筋無力症治療の世界市場 2020年 Market Overview The global Myasthenia Gravis Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Myasthenia Gravis…
- 子宮がん治療・診断の世界市場 2020年 Market Overview The global Uterine Cancer Therapies and Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Uteri…
- 緑内障レーザー治療の世界市場 2020年 Market Overview The global Glaucoma Laser Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Laser Thera…
- 緑内障手術療法の世界市場 2020年 Market Overview The global Glaucoma Surgery Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Surgery T…